Extended-release Parkinson’s therapy Crexont available in US
Crexont, an extended-release formulation of levodopa and carbidopa, is now available in pharmacies across the U.S. for people with…
Articles by Andrea Lobo
Certain diabetes medications tied to lower Parkinson’s, dementia risk
SGLT2 inhibitors, which are a type of medication to treat diabetes, may reduce the risk for neurodegenerative conditions, including…
Healthcare costs factor high in Parkinson’s economic burden
Healthcare services contribute to nearly half the total expenses associated with Parkinson’s disease, but the loss of productivity and…
Electroacupuncture reduced cellular signs of Parkinson’s in mouse model
Electroacupuncture reduced cellular hallmarks of Parkinson’s disease, including alpha-synuclein accumulation and nerve cell degeneration, in a mouse model of…
New panel of cell-based tests may help screen potential treatments
Ncardia has launched a panel of ready-to-use cell-based assays to simplify the screening and selection of treatment candidates for…
New biosensor can detect dopamine in unprocessed blood samples
A newly developed biosensor that can rapidly detect and quantify levels of dopamine — a chemical messenger nerve cells use…
Mood, cognition issues tied to deficit recognizing, describing emotions
Having difficulty recognizing and describing emotions may be associated with cognitive issues and with mood disorders such as depression, apathy,…
Rebrain’s AI software to optimize brain targeting approved by FDA
The U.S. Food and Drug Administration (FDA) has again cleared Rebrain’s OptimMRI software, this time including a new machine…
Parkinson’s Foundation awards 33 research grants worth $3M
The Parkinson’s Foundation said it awarded nearly $3 million in research grants to 33 recipients, aiming to accelerate innovative…
Migraines unlikely to increase the risk of Parkinson’s for women
Women with current or past migraines were not seen to be at a higher risk of developing Parkinson’s disease…